Can You Get A Hormone Test On Your Period? What To Know

A woman's menstrual cycle shifts hormone levels on a predictable schedule. That predictability is the reason testing during a period can sometimes produce more clinically interpretable results, not less. For several reproductive hormones, the first few days of menstruation are the preferred window for a baseline blood draw.

A hormone test on your period measures what circulates in venous blood at a specific point in the cycle. It doesn't interact with menstrual bleeding. The blood sample comes from a vein in the arm, not from the uterus. Cycle timing matters because it determines how a provider interprets the result, not whether the sample is usable. Women who are scheduling hormone blood testing for the first time can test during menstruation for most panels, as long as cycle day is documented and shared with the ordering provider.

Whether a hormone test should happen during menstruation, at mid-cycle, or in the luteal phase depends on which hormone is being measured and why. The sections below break down which markers belong in which window, what menstruation changes about iron and CBC results, and when it makes sense to wait.

Hormone Testing During Menstruation

The menstrual cycle has 4 phases, each with a different hormonal profile. Day 1 is the first day of full menstrual flow. From that point, estrogen and progesterone sit at their lowest concentrations during the early follicular phase (days 1-5), then rise and fall through the late follicular phase, ovulation, and the luteal phase.

That low-hormone window is why providers order many reproductive hormone panels during the first few days of bleeding. Baseline levels are easier to interpret when hormones aren't spiking. The Endocrine Society's 2015 menopause guideline references early-follicular FSH and estradiol measurement as part of evaluating menopausal transition in premenopausal women, consistent with standard reproductive endocrine practice (Stuenkel et al., 2015).

A single hormone result is a snapshot, not a full picture. Providers who order hormone levels checked through a telehealth lab panel account for cycle timing when they review results. Without cycle-day context, even an accurate number can be misread.

Which Hormones Are Best Tested During Your Period?

Several hormones produce their most interpretable baseline results when drawn during the early follicular phase, between cycle days 2 and 5.

FSH (follicle-stimulating hormone) and estradiol (E2) are the standard early-follicular pair. The ASRM Practice Committee identifies day-3 FSH and estradiol as components of ovarian reserve testing. An elevated FSH with a low or normal estradiol on day 3 may indicate declining ovarian function or premature ovarian insufficiency (POI), though a single value doesn't confirm the condition during perimenopause because of normal fluctuation (NICE, 2017).

LH (luteinizing hormone) is often drawn alongside FSH on the same early-follicular day. Drawing both allows providers to evaluate pituitary function as part of a broader reproductive workup.

AMH (anti-Mullerian hormone) is the exception. AMH levels remain relatively stable across the menstrual cycle, so AMH can be drawn on any cycle day. The ASRM Practice Committee notes that AMH is less cycle-day dependent than FSH or estradiol for female hormone testing.

Hormone Tests That Need a Different Cycle Day

Not every hormone should be tested during menstruation. Two groups are best timed to other cycle phases.

Progesterone and Mid-Luteal Timing

Progesterone rises after ovulation and peaks during the mid-luteal phase, about 7 days before the next expected period. NICE Clinical Guideline CG156 recommends mid-luteal serum progesterone (often labeled "day 21" for a 28-day cycle) to confirm ovulation. Testing progesterone during menstruation returns a predictably low value that doesn't inform a provider about whether ovulation occurred.

For cycles longer or shorter than 28 days, the draw should shift accordingly. For a 32-day cycle, a provider might target approximately day 25, though individual timing should be confirmed based on cycle tracking and clinical evaluation. Tracking basal body temperature or using an ovulation predictor kit can help identify the right window. Providers at Marek Diagnostics can guide blood test preparation based on individual cycle length.

Testosterone, DHEA-S, and SHBG in Women

Testosterone, DHEA-S, and SHBG (sex hormone-binding globulin) can be drawn on any cycle day in women, though early-follicular timing is sometimes preferred to avoid mid-cycle fluctuations. Morning draws are standard for testosterone because of diurnal variation. Levels are highest in the early morning and decline through the afternoon.

These markers matter in PCOS evaluation, where elevated testosterone or a low SHBG can help clarify the hormonal pattern. For women on hormone replacement therapy, a perimenopause panel that includes estrogen alongside testosterone and SHBG provides a more complete assessment.

How Does Menstruation Affect Iron and CBC Results?

A complete blood count (CBC) drawn during a period isn't invalid. But heavy menstrual bleeding can lower hemoglobin, hematocrit, and ferritin enough to change clinical interpretation.

ACOG defines heavy menstrual bleeding as bleeding lasting more than 7 days, soaking through a pad or tampon in under 2 hours, or passing large clots. Repeated heavy cycles deplete stored iron. Ferritin, which reflects iron storage rather than circulating iron, may drop before hemoglobin does. A woman can have a normal hemoglobin level while her ferritin is already low.

Women who experience heavy periods and symptoms like persistent fatigue, lightheadedness, or reduced exercise tolerance should mention these details when prepping for blood work. A provider may request ferritin, serum iron, and transferrin saturation in addition to a standard CBC to get a clearer picture of iron status. Drawing mid-cycle, when acute blood loss isn't occurring, can produce a more stable baseline for iron markers.

Does Your Period Affect Thyroid or Metabolic Tests?

Thyroid function tests, including TSH, free T4, and free T3, aren't meaningfully altered by menstruation. These markers can be drawn on any cycle day. Morning draws are preferred for TSH because TSH follows a diurnal pattern, peaking in the early morning and dropping by afternoon.

One important detail: biotin (vitamin B7) supplements can interfere with certain immunoassay-based lab tests, including thyroid panels. The FDA issued a safety communication warning that biotin interference has led to incorrect test results. Clients should stop biotin supplements at least 72 hours before a blood draw. This applies regardless of cycle day.

Lipid panels and fasting glucose may show minor variation across the menstrual cycle. Providers generally observe that cholesterol levels tend to be more stable during the menstrual phase and may fluctuate during the late follicular and luteal phases. For consistent tracking over time, providers often recommend drawing metabolic panels at the same cycle phase each time. Women managing stress and hormone levels through a telehealth provider should coordinate metabolic and hormonal draws on the same visit when possible.

Cortisol testing follows its own timing rules. Morning draws (before 10 AM) produce the most interpretable values because cortisol peaks shortly after waking and declines throughout the day. Cycle day doesn't affect cortisol in the same way it affects reproductive hormones, so cortisol can be drawn at any point in the menstrual cycle.

What About Irregular Cycles or Hormonal Contraception?

Not every woman has a predictable 28-day cycle. Irregular periods are common during perimenopause, with PCOS, and after discontinuing hormonal contraception.

For irregular cycles, providers may draw labs on any day bleeding starts and document the interval since the last period. Multiple measurements over several weeks often produce more useful information than a single result. The Endocrine Society's menopause guideline notes that replicate FSH and estradiol measurements may support a presumptive menopause assessment in women whose menstrual history doesn't provide a clear answer (Stuenkel et al., 2015).

Combined hormonal methods (pills, patches, rings) suppress ovulation and flatten the natural cycle. Progestin-only methods, including hormonal IUDs and progestin-only pills, vary in their effect on ovulation, with some suppressing it and others acting primarily through local mechanisms. In either case, providers need to know which method is in use before ordering or interpreting hormone panels. FSH, LH, estradiol, and progesterone results on combined hormonal contraception won't reflect natural ovarian function.

Women interested in reviewing individual biomarker tests while on birth control should discuss timing and expectations with a provider before the draw. In some cases, testing is deferred until after discontinuation to get a true baseline.

One additional note for women 45 and older with typical menopausal symptoms: the Menopause Society's 2022 position statement notes that routine serum hormone testing is rarely required before starting indicated hormone therapy. In those cases, the decision rests on symptoms, medical history, and shared decision-making rather than a specific lab value.

When to Reschedule a Hormone Blood Draw

Most women don't need to reschedule a blood draw because their period started. For FSH, LH, and estradiol, the early follicular window during menstruation is the recommended time for baseline assessment. For thyroid, cortisol, AMH, and most metabolic markers, cycle day doesn't change the result.

Rescheduling may make sense in 3 situations. The first: a mid-luteal progesterone test was ordered and the period arrived early, meaning ovulation may not have occurred when expected. The second: heavy bleeding is accompanied by dizziness, lightheadedness, or a history of fainting during blood draws. The third: iron-panel results are the priority and the provider wants to avoid acute-loss interference.

If there's any uncertainty, contacting the ordering provider is the simplest step. Marek Diagnostics offers scheduling tools and provider access to help clients time their labs correctly based on cycle length and clinical goals.

What to Share With a Provider Before Testing

Accurate interpretation depends on context. The following details help a provider read hormone results correctly:

• First day of the most recent period (cycle day 1)

• Current cycle day at the time of the draw

• Whether flow is lighter or heavier than usual

• Any hormonal contraception, hormone therapy, or fertility medications

• Biotin or iron supplements taken in the past 72 hours

• Fasting status if fasting was requested

• History of fainting or difficult blood draws

Cycle day is one of the most useful details for hormone testing. Day 1 is the first day of full menstrual bleeding, not spotting. If a woman's period started Monday and the blood draw happens Wednesday, that's approximately cycle day 3.

For women who want to get a hormone test on their period, Marek Diagnostics makes it simple to time the draw correctly. Sharing cycle day when building a bundled lab panel helps providers select the right window and interpret results within the correct clinical frame.

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

Can you get a hormone test on your period?

Yes. For many reproductive hormones, the early follicular phase (cycle days 2-5) is the standard testing window. FSH, LH, and estradiol are often drawn during menstruation because levels sit at a stable baseline. The blood sample comes from an arm vein and isn't affected by menstrual flow.

Which hormones should be tested during menstruation?

FSH, LH, and estradiol are best tested during cycle days 2-5. The ASRM Practice Committee identifies day-3 FSH and estradiol as part of standard ovarian reserve assessment. AMH can be tested on any cycle day because it doesn't fluctuate with the menstrual cycle.

When should progesterone be tested?

Progesterone should be drawn during the mid-luteal phase, about 7 days after ovulation. For a 28-day cycle, that's approximately day 21. NICE Clinical Guideline CG156 recommends this window to confirm ovulation. Testing progesterone during menstruation returns a predictably low result that doesn't provide clinical information about ovulatory function.

Does your period affect thyroid test results?

Menstruation doesn't meaningfully alter TSH, free T4, or free T3 results. Thyroid panels can be drawn on any cycle day. Morning draws are preferred because TSH follows a diurnal pattern. Biotin supplements should be stopped at least 72 hours before any thyroid blood draw, as the FDA has warned about biotin interference with immunoassay-based tests.

Can heavy periods affect blood test results?

Heavy menstrual bleeding can lower hemoglobin, hematocrit, and ferritin in a CBC or iron panel. ACOG notes that heavy menstrual bleeding can lead to iron-deficiency anemia. Women with heavy periods may get more stable iron-panel results by drawing mid-cycle rather than during active bleeding.

Should you reschedule a blood test because of your period?

In most cases, no. Early follicular draws are the correct window for FSH, LH, and estradiol. Thyroid, AMH, cortisol, and metabolic panels aren't cycle-day dependent. Rescheduling makes sense only if the provider specifically ordered a mid-luteal progesterone test and the period arrived earlier than expected, or if heavy bleeding is causing symptoms like dizziness.

How does hormonal contraception affect hormone testing?

Combined hormonal methods (pills, patches, rings) suppress ovulation and flatten the natural cycle. Progestin-only methods, including hormonal IUDs and progestin-only pills, vary in their effect on ovulation. FSH, LH, estradiol, and progesterone results on combined hormonal contraception won't reflect natural ovarian function. Providers should know which method is in use before ordering or interpreting a hormone panel.

References

• Fertil Steril. 2020;114(3):535-550

• J Clin Endocrinol Metab. 2015;100(11):3975-4011

• FDA Safety Communication: Biotin Interference with Lab Tests. 2019

• NICE Clinical Guideline CG156: Fertility Problems. 2013 (updated 2017)

• Menopause. 2022;29(7):767-794